Core A functions to provide the leadership, interaction and co-ordination between the different projects of the PPG in order to facilitate them in meeting their scientific goals. It can be divided into two sections: scientific support and administrative support. Important functions of the scientific support will be: to organize and hold weekly meetings of the project leaders and key personnel, to hold executive meetings of the project leaders alone to review progress and scientific direction, and to hold annual reviews with an external advisory board to review progress on the overall goals of the PPG as a whole. Important aspects of administrative support will be to monitor the dispersion of financial resources, monitor research allocations. The steering committee composed of all four project leaders will meet twice a year to review expenditures and resource allocations for the projects and cores. The administrative core will also be responsible for writing and transmitting the yearly progress report on the PPG, including the written report of the External Advisory Committee. An additional function of the administrative core will be to disseminate a program for seminars at Stanford that are broadly related to the scientific directions of the PPG. A final aspect of the scientific support will be to ensure that all investigators are using common reagents and cell strains to maintain uniformity in experimental protocols.

Public Health Relevance

The success of a Program Project Grant involves fiscal and administrative management, and coordination between projects and cores. In addition, the increase paperwork has driven the need for an administrative core. This core works hard to ensure that all the Project and Core leaders can focus on their science.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA067166-17
Application #
8744824
Study Section
Special Emphasis Panel (ZCA1-RPRB-2)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
17
Fiscal Year
2014
Total Cost
$83,634
Indirect Cost
Name
Stanford University
Department
Type
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Vilalta, Marta; Brune, Jourdan; Rafat, Marjan et al. (2018) The role of granulocyte macrophage colony stimulating factor (GM-CSF) in radiation-induced tumor cell migration. Clin Exp Metastasis 35:247-254
Tandon, Neha; Thakkar, Kaushik N; LaGory, Edward L et al. (2018) Generation of Stable Expression Mammalian Cell Lines Using Lentivirus. Bio Protoc 8:
Yang, Zhifen; Zhang, Jing; Jiang, Dadi et al. (2018) A Human Genome-Wide RNAi Screen Reveals Diverse Modulators that Mediate IRE1?-XBP1 Activation. Mol Cancer Res 16:745-753
Benej, Martin; Hong, Xiangqian; Vibhute, Sandip et al. (2018) Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism. Proc Natl Acad Sci U S A 115:10756-10761
Rafat, Marjan; Aguilera, Todd A; Vilalta, Marta et al. (2018) Macrophages Promote Circulating Tumor Cell-Mediated Local Recurrence following Radiotherapy in Immunosuppressed Patients. Cancer Res 78:4241-4252
Saiki, Julie P; Cao, Hongbin; Van Wassenhove, Lauren D et al. (2018) Aldehyde dehydrogenase 3A1 activation prevents radiation-induced xerostomia by protecting salivary stem cells from toxic aldehydes. Proc Natl Acad Sci U S A 115:6279-6284
Olcina, Monica M; Kim, Ryan K; Melemenidis, Stavros et al. (2018) The tumour microenvironment links complement system dysregulation and hypoxic signalling?. Br J Radiol :20180069
Jiang, Dadi; Turner, Brandon; Song, Jie et al. (2017) Comprehensive Analysis of the Unfolded Protein Response in Breast Cancer Subtypes. JCO Precis Oncol 2017:
Weyandt, Jamie D; Thompson, Craig B; Giaccia, Amato J et al. (2017) Metabolic Alterations in Cancer and Their Potential as Therapeutic Targets. Am Soc Clin Oncol Educ Book 37:825-832
Kariolis, Mihalis S; Miao, Yu Rebecca; Diep, Anh et al. (2017) Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest 127:183-198

Showing the most recent 10 out of 203 publications